In the EU, Merz Aesthetics® announced today the approval for Radiesse® to treat the décolleté area. Radiesse® is a regenerative biostimulator capable of regenerating multiple components of the skin tissue, resulting in healthier-looking skin, and is now approved for use in the décolletage, adding to the product’s versatility.
This new regulatory milestone directly answers patient demand, given there is a significant shift toward regenerative biostimulation as a preferred method of aesthetic treatment for patients. Google Trends Data further support this showcasing a continual surge in searches for ‘collagen’ between 2016–2022, confirming a shift in aesthetic preferences for patients.
‘Despite being one of the most visible areas of our bodies, the décolleté area is often overlooked when it comes to aesthetics’ says Dr. Samantha Kerr, Chief Scientific Officer, Merz Aesthetics®. ‘Radiesse® presents a unique solution to improving décolleté wrinkles and provides our customers and their patients a non-surgical, effective option to address aging décolleté skin.’
Recent data from the ‘International Society of Aesthetic Plastic Surgery’ reveal a 171.8% increase in worldwide non-surgical procedures minimally invasive treatments between 2018 and 2022 involving calcium hydroxylapatite further showcasing the patient need.
A number of studies, including this large, multicentre clinical trial have supported the décolleté approval and has provided substantial evidence of Radiesse®’s effectiveness, demonstrating a significant improvement in the appearance of décolleté wrinkles. The various studies have found that up to 73.5% of patients experienced improved décolleté wrinkles, 16 weeks after their last treatment. Furthermore, 76.1% of patients demonstrated an enhancement in skin quality over the same period.
Notably, physicians reported a high level of satisfaction among 77% of patients 16 weeks after their last treatment.
